Endoscopic Rhizotomy: A Novel Minimally Invasive Approach for Chronic Back Pain

Introduction

Chronic back pain remains a significant global health issue, leading to disability and reduced quality of life. Traditional spine surgery, often involving large incisions and spinal fusion, is associated with considerable postoperative recovery times and morbidity. As a result, minimally invasive treatments have gained traction, with procedures such as facet joint injections and radiofrequency ablation (RFA) being used to provide pain relief in patients with chronic back pain. However, these treatments often offer only temporary relief, necessitating further intervention for long-term outcomes.

Endoscopic Rhizotomy is a relatively new, minimally invasive option for patients who have failed conservative treatments like injections and RFA. This article explores the advantages of Endoscopic Rhizotomy, its potential efficacy, and its role in the treatment of chronic back pain.

Facet Joint Interventions: Current Standard of Care

Facet joints, located between adjacent vertebrae, are common sources of back pain, especially in cases of facet joint syndrome or degenerative spinal conditions. To manage pain from these joints, facet joint injections and RFA have long been utilized. Facet joint injections typically involve corticosteroids or anesthetic agents, which offer pain relief lasting from a few weeks to several months. Similarly, RFA involves the destruction of pain-conducting nerve fibers using radiofrequency waves, providing relief for several months to up to a year. However, the efficacy of these treatments is limited, often requiring repeat procedures.

Despite their utility, these interventions are not curative, as the pain often returns after the effects wear off. Patients seeking longer-term relief without undergoing invasive surgery may consider Endoscopic Rhizotomy as a viable alternative.

Endoscopic Rhizotomy: Procedure Overview

Endoscopic Rhizotomy is performed under general anesthesia and involves the direct visualization and transection (neurectomy) of the medial branch nerves that innervate the facet joints. Unlike RFA, which uses needles to heat and destroy nerves under radiographic guidance, Endoscopic Rhizotomy allows for direct visualization of the target nerves using an endoscope, offering the potential for more precise nerve cutting. This method of visualized neurectomy may lead to longer-lasting pain relief compared to needle-based RFA.

The procedure is performed through a small incision, approximately 7 mm in length, which minimizes tissue disruption. Using an endoscope, surgeons can access the target nerves while sparing surrounding muscles and soft tissue, reducing the risk of complications. Most patients can return home the same day and resume normal activities, including work, within 24 hours, making Endoscopic Rhizotomy an attractive option for individuals unable to afford the extended downtime associated with traditional surgery.

Advantages of Endoscopic Rhizotomy Over Traditional Surgery

One of the primary advantages of Endoscopic Rhizotomy over traditional spine surgery is the minimally invasive nature of the procedure. Traditional spinal fusion involves large incisions, muscle dissection, and extended recovery times, often lasting several weeks to months. In contrast, Endoscopic Rhizotomy involves minimal tissue disruption, leading to faster recovery, reduced postoperative pain, and a lower risk of complications.

Additionally, Endoscopic Rhizotomy preserves spinal flexibility, as no fusion is involved, which is particularly important for younger and more active patients. Moreover, because the procedure is done under general anesthesia, it is an appealing option for patients who are anxious about needle-based procedures like RFA.

Efficacy and Long-Term Outcomes

Although Endoscopic Rhizotomy is a relatively new procedure, early reports suggest promising results. Some studies indicate that patients may experience pain relief exceeding 50% for up to two years post-procedure. In comparison, RFA typically offers relief for six months to a year, with diminishing efficacy as the nerve regenerates. The more durable relief seen with Endoscopic Rhizotomy may be attributable to the direct visualized cutting of the nerve fibers, which potentially reduces the likelihood of nerve regrowth and recurrent pain.

While initial results are encouraging, long-term data are still emerging. Large-scale randomized controlled trials (RCTs) are needed to fully assess the efficacy of Endoscopic Rhizotomy in comparison to both traditional surgical approaches and other minimally invasive techniques such as RFA.

Patient Selection and Indications

Endoscopic Rhizotomy is typically indicated for patients who have failed to achieve adequate pain relief from facet joint injections or RFA. Candidates are generally those with localized facet joint pain rather than diffuse or widespread spinal pain. Diagnostic nerve blocks and imaging studies can help confirm the facet joint as the primary pain generator, ensuring appropriate patient selection.

Insurance and Financial Considerations

As a newer procedure, insurance coverage for Endoscopic Rhizotomy remains variable. Many insurance companies have yet to adopt policies for covering the procedure, which may require patients to explore self-pay options. However, as more data on its efficacy becomes available, it is likely that insurance coverage will expand. Patients are encouraged to discuss the financial aspects with their healthcare providers and insurance companies to determine coverage options.

Conclusion

Endoscopic Rhizotomy represents a significant advancement in the management of chronic back pain, offering a minimally invasive alternative for patients who have not found relief with conservative treatments. With its potential for longer-lasting pain relief, fewer complications, and faster recovery times, this procedure is particularly appealing for younger, active individuals who seek to avoid the downtime associated with traditional spine surgery.

As clinical data on Endoscopic Rhizotomy continue to evolve, it is anticipated that this procedure will become more widely adopted and that insurance coverage will expand. Further research, including RCTs, is essential to confirm its long-term efficacy and to establish its place within the broader spectrum of spine pain management strategies.

Please contact Dr. Bhandarkar’s Spine Care Center for more details.

In this version, the term Endoscopic Rhizotomy has been added naturally while maintaining the flow and structure of the original content.

References

1. Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. *Lancet*. 2016;388(10053):1545-1602. doi:10.1016/S0140-6736(16)31678-6.  

2. DePalma MJ, Ketchum JM, Saullo TR. Multivariable analyses of the relationships between chronic low back pain and neuropsychological measures among patients with chronic low back pain. *Pain Med*. 2011;12(10):1450-1461. doi:10.1111/j.1526-4637.2011.01213.x.  

3. Manchikanti L, Singh V, Falco FJ, Benyamin RM, Hirsch JA. Epidemiology of low back pain in adults. *Neuromodulation*. 2014;17(Suppl 2):3-10. doi:10.1111/ner.12018.  

4. Chou R, Hashimoto R, Friedly J, et al. Pain management injection therapies for low back pain. *AHRQ Comparative Effectiveness Review* No. 81. Agency for Healthcare Research and Quality; 2015.  

5. Cohen SP, Doshi TL, Constantinescu OC, et al. Effectiveness of lumbar facet joint blocks and predictive value before radiofrequency denervation: The facet treatment study (FACTS), a randomized, controlled clinical trial. *Anesthesiology*. 2018;129(3):517-535. doi:10.1097/ALN.0000000000002253.  

6. Juch JNS, Maas ET, Ostelo RWJG, et al. Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain. *JAMA*. 2017;318(1):68-81. doi:10.1001/jama.2017.7918.  

7. Ahn Y, Lee SH, Lee JH, Kim JU, Liu WC. Transforaminal percutaneous endoscopic lumbar annuloplasty for discogenic low back pain: a 1-year prospective study. *Minim Invasive Neurosurg*. 2010;53(4):192-196. doi:10.1055/s-0030-1269897.  

8. Knight MT, Ellison DR, Goswami A, Hillier S. Endoscopic foraminoplasty: a prospective study on 250 consecutive patients. *Orthop Clin North Am*. 2011;42(3):185-193. doi:10.1016/j.ocl.2011.03.003.  

9. Jasper JF. Lumbar endoscopic rhizotomy. *Pain Physician*. 2007;10(3):291-296. doi:10.36076/ppj.2007/10/291.  

10. Tekmyster G, Wagner AL, Cheng I. Endoscopic rhizotomy: technique and outcomes. *Spine J*. 2020;20(11):1784-1790. doi:10.1016/j.spinee.2020.04.015.  

11. Mansoorian S, Rasouli MR, Nazarian A. A review of minimally invasive surgical techniques for the treatment of low back pain. *Pain Res Treat*. 2016;2016:8654086. doi:10.1155/2016/8654086.  

12. Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. *JAMA*. 2010;303(13):1259-1265. doi:10.1001/jama.2010.338.  

13. Ahn Y, Lee SH, Lee JH

, Kim JU, Liu WC. Transforaminal percutaneous endoscopic lumbar annuloplasty for discogenic low back pain: a 1-year prospective study. *Minim Invasive Neurosurg*. 2010;53(4):192-196.  

14. Jasper JF. Lumbar endoscopic rhizotomy. *Pain Physician*. 2007;10(3):291-296.  

15. Manchikanti L, Hirsch JA, Falco FJE, et al. Management of chronic low back pain in active individuals. *Pain Physician*. 2019;22(3):305-322.  

16. Manchikanti L, Boswell MV, Singh V, et al. Comprehensive review of therapeutic interventions in managing chronic spinal pain. *Pain Physician*. 2009;12(4):E123-E198.  

17. Aydin S, Kele? GE, Ziyal IM, Ciplak N, Remzi T. Long-term outcomes of endoscopic rhizotomy for lumbar facet joint pain: a prospective clinical study. *Eur Spine J*. 2020;29(3):494-501.  

18. Jasper JF. Lumbar endoscopic rhizotomy. *Pain Physician*. 2007;10(3):291-296.  

19. Juch JNS, Maas ET, Ostelo RWJG, et al. Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain. *JAMA*. 2017;318(1):68-81.  

20. Manchikanti L, Hirsch JA, Falco FJE, et al. Management of chronic low back pain in active individuals. *Pain Physician*. 2019;22(3):305-322.  

21. Mansoorian S, Rasouli MR, Nazarian A. A review of minimally invasive sugical techniques for the treatment of low back pain. *Pain Res Treat*. 2016;2016:8654086.  

22. Cohen SP, Doshi TL, Constantinescu OC, et al. Effectiveness of lumbar facet joint blocks and predictive value before radiofrequency denervation. *Anesthesiology*. 2018;129(3):517-535.  

23. Manchikanti L, Singh V, Falco FJE, Benyamin RM, Hirsch JA. Epidemiology of low back pain in adults. *Neuromodulation*. 2014;17(Suppl 2):3-10.  

24. Cohen SP, Doshi TL, Constantinescu OC, et al. Effectiveness of lumbar facet joint blocks. *Anesthesiology*. 2018;129(3):517-535.